Avenue Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:49Y Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
05 Nov 24	Sell€125	Jay Kranzler	Individual	61	€2.05
30 Sep 24	Buy€1,120	Jay Kranzler	Individual	500	€2.24
11 Dec 23	Sell€80,570	Robert Davidow	Individual	8,226.65	€10.47

Insider Buying: 49Y insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 710.4%.

Top 17 shareholders own 28.04% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.6%	Fortress Biotech, Inc.	179,907	€344.5k	280%	no data
8.03%	Armistice Capital LLC	115,000	€220.2k	53.3%	0.01%
4.41%	Sabby Management, LLC	63,060	€120.8k	68.6%	1.23%
1.2%	Robert Davidow	17,206	€33.0k	0%	no data
0.77%	Moss Adams Wealth Advisors LLC	11,000	€21.1k	0%	no data
0.43%	UBS Asset Management AG	6,143	€11.8k	813%	no data
0.33%	Lindsay Rosenwald	4,671	€8.9k	0%	no data
0.12%	Tower Research Capital Europe Limited	1,740	€3.3k	-45.7%	no data
0.049%	Geode Capital Management, LLC	695	€1.3k	0%	no data
0.043%	The Vanguard Group, Inc.	617	€1.2k	0%	no data
0.039%	Wells Fargo & Company, Securities and Brokerage Investments	561	€1.1k	820%	no data
0.039%	Jay Kranzler	559	€1.1k	-9.84%	no data
0.0084%	Neil Herskowitz	120	€229.7	0%	no data
0.0031%	Curtis Oltmans	44	€84.2	0%	no data
0.0007%	Bank of America Corporation, Asset Management Arm	10	€19.2	42.9%	no data
0.00056%	EMFO, LLC	8	€15.4	0%	no data
0.00007%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	€1.9	0%	no data